- EUR/USD has been falling after an ECB hinted at lowering the euro.
- The Federal Reserve's decision is set to rock markets later in the day.
- Wednesday's four-hour chart is pointing to further falls for the pair.
Klaas Knot has been hitting the common currency – the mostly unknown member of the European Central Bank has said that his institution has the tools to counter the appreciation of the euro. The Dutch ECB member has gone further than his boss, President Christine Lagarde, and also said that the Frankfurt-based institution could cut interest rates. He tied any future policy moves to the bank's single mandate – inflation.
Knot's comments come one day after the media reported that the ECB is investigating the impact of the US Federal Reserve's policies on the exchange rate – and the latter's effect on price development. Will the Fed indeed send the dollar down and complicate the ECB's task?
The world's most powerful central bank convenes later in the day and is set to leave its bond-buying scheme unchanged amid speculation about its next moves. Jerome Powell, Chairman of the Federal Reserve, will likely reject any calls to taper down the bond-buying scheme amid ongoing hardship. Help from the Fed may be needed to fund government debt if President Joe Biden is successful in passing most of his ambitious $1.9 trillion fiscal stimulus deal.
The recent exuberance in several stocks – namely Gamestop – may change Powell's mind. Reporters will likely quiz the Fed Chair about market exuberance and also about upbeat prospects about the economy in the latter half of 2021 – especially as the US is ramping up vaccine production and deployment.
- Fed Preview: Fearing market froth or boosting Biden's stimulus? Three scenarios
- US Federal Reserve Preview: Neither an optimist nor a pessimist be
Ahead of the Fed, US Durable Goods Orders are set to show a slower increase in investment in December. See US Durable Goods Orders December Preview: Have job losses tipped over the consumer market?
On the other side of the pond, immunization is advancing at a snail's pace – with pharmaceuticals and governments blaming each other for the delay. AstraZeneca and Brussels are at loggerheads over the delay even before the EU regulator approved the British firm's jabs. A final seal is due on Friday.
Italy continues grappling with its political issues in the middle of the covid crisis. Prime Minister Giuseppe Conte is trying to form a new government one day after tendering his resignation.
Overall, clouds are darkening over the euro while things look rosier in the US. All eyes are now on the Fed.
EUR/USD Technical Analysis
Euro/dollar has dropped below the 50 Simple Moving Average on the four-hour chart and momentum is to the downside. The pair also trades below the 100 and 200 SMAs.
Critical support is at 1.21, the weekly low and also a psychologically significant level. The next levels to watch are 1.2050 and 1.2075, both stepping stones on the way up. Further below, 1.20 and 1.1960 are eyed.
Resistance awaits at 1.2150, a separator of ranges last week, and then by the all-important 1.2190 cap – last week's peak and where the 200 SMA hits the price.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.